|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Á¦ ¸ñ |
aAXaTWkbhHTUHI |
|
ÀÌ ¸§ |
Santos |
³¯ Â¥ |
2018/06/27 |
Á¶ ȸ |
6 |
|
Who do you work for? prescription drugs for lack of energy The researchers reported that the 265 patients on the study treated with a targeted drug had a median survival of 3.5 years from diagnosis, compared with 2.1 years for the 361 patients for whom a mutation wasn't identified.
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|